175 related articles for article (PubMed ID: 1678580)
41. Angina, ischemia, and effort tolerance with vasodilating beta-blockers.
Dargie HJ; Grant S; McLenachan J
Am Heart J; 1991 Mar; 121(3 Pt 2):1017-20. PubMed ID: 1671726
[TBL] [Abstract][Full Text] [Related]
42. Different effects of beta-1-adrenergic blocking agents with ISA or without ISA on peripheral blood flow.
Karnik R; Valentin A; Slany J
Angiology; 1987 Apr; 38(4):296-303. PubMed ID: 2883920
[TBL] [Abstract][Full Text] [Related]
43. Long-term humoral and hemodynamic effects of celiprolol.
Lucarini AR; Simonini N; Palmieri L; Salvetti A
Am J Hypertens; 1988 Jul; 1(3 Pt 3):211S-213S. PubMed ID: 2970852
[TBL] [Abstract][Full Text] [Related]
44. Long-term beta 1-adrenergic blockade restores adrenomedullary activity in primary hypertension.
Jacobs MC; Lenders JW; Smits P; Willemsen JJ; Tack C; Thien T
J Cardiovasc Pharmacol; 1997 Sep; 30(3):338-42. PubMed ID: 9300318
[TBL] [Abstract][Full Text] [Related]
45. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Omvik P; Lund-Johansen P; Haugland H
Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925
[TBL] [Abstract][Full Text] [Related]
46. Improved left ventricular function during exercise: a comparison of celiprolol and atenolol.
McLenachan J; Wilson J; Dargie H
Am Heart J; 1988 Nov; 116(5 Pt 2):1435-6. PubMed ID: 2903655
[No Abstract] [Full Text] [Related]
47. Daytime-selective antihypertensive activity of celiprolol.
Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
[TBL] [Abstract][Full Text] [Related]
48. Beta-blockers and nitrates in patients with peripheral arterial occlusive disease: long-term findings.
Schweizer J; Kaulen R; Nierade A; Altmann E
Vasa; 1997; 26(1):43-6. PubMed ID: 9068264
[TBL] [Abstract][Full Text] [Related]
49. Comparison of the effects of pindolol and atenolol on hemodynamic function in systemic hypertension.
Toth PD; Demeter RJ; Woods JR; Nyhuis AW; Judy WV
Am J Cardiol; 1988 Sep; 62(7):413-8. PubMed ID: 3414518
[TBL] [Abstract][Full Text] [Related]
50. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
Br J Clin Pharmacol; 1986 Dec; 22(6):697-706. PubMed ID: 2882772
[TBL] [Abstract][Full Text] [Related]
51. Quality of life before and during antihypertensive treatment: a comparative study of celiprolol and atenolol.
Cleophas TJ; vd Mey N; Meulen J; Niemeyer MG
Am J Ther; 1997 Apr; 4(4):117-22. PubMed ID: 10423600
[TBL] [Abstract][Full Text] [Related]
52. Vasodilatory beta-blockers: systemic and regional hemodynamic effects.
Frohlich ED
Am Heart J; 1991 Mar; 121(3 Pt 2):1012-6; discussion 1016-7. PubMed ID: 1671725
[TBL] [Abstract][Full Text] [Related]
53. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
O'Callaghan WG; Laher MS; McGarry K; O'Brien E; O'Malley K
Br J Clin Pharmacol; 1983 Oct; 16(4):417-21. PubMed ID: 6138058
[TBL] [Abstract][Full Text] [Related]
54. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
Ruilope LM
Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
[TBL] [Abstract][Full Text] [Related]
55. Clinical pharmacology of vasodilatory beta-blocking drugs.
Shanks RG
Am Heart J; 1991 Mar; 121(3 Pt 2):1006-11. PubMed ID: 1671724
[TBL] [Abstract][Full Text] [Related]
56. [Therapeutic effect of the cardioselective beta-blocking agent tenormin and its action on the indices of systemic, intracardiac and regional hemodynamics in patients with hypertension].
Erina EV; Charyev KhE; Oshchepkova EV
Kardiologiia; 1983 Apr; 23(4):53-9. PubMed ID: 6865186
[TBL] [Abstract][Full Text] [Related]
57. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
[TBL] [Abstract][Full Text] [Related]
58. Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease.
Silke B; Verma SP; Sharma SK; Frais MA; Reynolds G; Taylor SH
J Cardiovasc Pharmacol; 1989 Jan; 13(1):155-61. PubMed ID: 2468927
[TBL] [Abstract][Full Text] [Related]
59. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Schalekamp MA
Circulation; 1988 Oct; 78(4):957-68. PubMed ID: 3048776
[TBL] [Abstract][Full Text] [Related]
60. The effect of the cardioselective beta blocker celiprolol on pulmonary function in asthmatic patients.
Schindl R; Würtz J; Hoffmann H
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S99-101. PubMed ID: 2427862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
